Paulson Richard A. sold KPTI
May 14, 2026 · Form 4 insider transaction
Paulson Richard A. sold 2,203 shares of Karyopharm Therapeutics Inc. at $9.50 per share, a transaction worth $20.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,203
Price
$9.50
Total value
$20.9K
InsiderPaulson Richard A.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 14, 2026
Filing dateMay 15, 2026
Shares owned after269,747
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.